Pharmerica Corporation (PMC)

Pharmerica Corporation (PMC) Healthcare & Pipeline Overview

Pharmerica Corporation (PMC) provides pharmacy and related consulting services to long-term care facilities, differentiating itself through specialized medication management programs and a focus on cost-effective solutions. With a P/E ratio of 41.57 and a profit margin of 1.0%, the company operates in a competitive healthcare services market.

What Is the Investment Thesis for PMC?

Pharmerica Corporation presents a mixed investment thesis. The company's established position in the long-term care pharmacy market provides a stable revenue base. However, the relatively low profit margin of 1.0% raises concerns about operational efficiency and pricing power. A key value driver is the increasing demand for specialized pharmacy services in the aging population. Growth catalysts include expanding clinical consulting services and leveraging technology to improve medication management. Potential risks include regulatory changes, reimbursement pressures, and competition from other pharmacy providers. Investors should closely monitor Pharmerica's ability to improve profitability and capitalize on growth opportunities in the long-term care market.

Based on FMP financials and quantitative analysis

PMC Key Highlights

• P/E ratio of 41.57, indicating a relatively high valuation compared to earnings.
• Profit margin of 1.0%, reflecting potential challenges in operational efficiency and pricing.
• Gross margin of 15.6%, suggesting room for improvement in cost management.
• Beta of 0.93, indicating slightly lower volatility compared to the overall market.
• No dividend yield, meaning investors do not receive income from dividends.

What Are PMC's Key Strengths?

• Established market position in long-term care pharmacy services.
• Comprehensive suite of pharmacy and consulting services.
• Strong relationships with long-term care facilities.
• Expertise in medication management for geriatric patients.

What Are PMC's Weaknesses?

• Relatively low profit margin.
• Dependence on long-term care facilities.
• Exposure to regulatory changes and reimbursement pressures.
• Limited geographic diversification.

What Could Drive PMC Stock Higher?

• Expansion of clinical consulting services to drive revenue growth.
• Implementation of technology solutions to improve medication management and patient safety.
• Strategic partnerships with healthcare providers to expand market reach.

What Are the Key Risks for PMC?

• Insider selling — insiders were net sellers of roughly $19.2M recently.
• Regulatory changes affecting pharmacy practices and reimbursement rates.
• Increased competition from other pharmacy providers.
• Economic downturn affecting long-term care facilities and their ability to pay for pharmacy services.
• Changes in healthcare delivery models that reduce the need for long-term care facilities.

What Are the Growth Opportunities for PMC?

• Expansion of Clinical Consulting Services: Pharmerica can expand its clinical consulting services to provide more comprehensive medication management solutions to long-term care facilities. The market for clinical consulting services in the healthcare industry is estimated to be worth $30 billion annually. By offering specialized consulting services, Pharmerica can increase its revenue per customer and improve patient outcomes. Timeline: Ongoing.
• Leveraging Technology for Medication Management: Pharmerica can leverage technology to improve medication management and enhance patient safety. The market for medication management technology is projected to reach $5 billion by 2028. By implementing electronic health record integration, medication adherence programs, and other technology solutions, Pharmerica can differentiate itself from competitors and attract new customers. Timeline: Ongoing.
• Strategic Partnerships with Healthcare Providers: Pharmerica can form strategic partnerships with healthcare providers to expand its reach and offer integrated pharmacy solutions. The market for healthcare partnerships is estimated to be worth $10 billion annually. By partnering with hospitals, physician groups, and other healthcare organizations, Pharmerica can gain access to new markets and customers. Timeline: Ongoing.
• Acquisition of Regional Pharmacy Providers: Pharmerica can acquire regional pharmacy providers to consolidate its market position and expand its geographic reach. The market for pharmacy acquisitions is estimated to be worth $5 billion annually. By acquiring smaller pharmacy providers, Pharmerica can increase its market share and achieve economies of scale. Timeline: Ongoing.
• Development of Specialized Pharmacy Programs: Pharmerica can develop specialized pharmacy programs tailored to the unique needs of specific patient populations, such as patients with dementia or chronic conditions. The market for specialized pharmacy programs is estimated to be worth $2 billion annually. By offering specialized programs, Pharmerica can attract new customers and improve patient outcomes. Timeline: Ongoing.

What Opportunities Does PMC Have?

• Expansion of clinical consulting services.
• Leveraging technology for medication management.
• Strategic partnerships with healthcare providers.
• Acquisition of regional pharmacy providers.

What Threats Does PMC Face?

• Competition from other pharmacy providers.
• Regulatory changes and reimbursement pressures.
• Economic downturn affecting long-term care facilities.
• Changes in healthcare delivery models.

What Are PMC's Competitive Advantages?

• Established relationships with long-term care facilities.
• Specialized expertise in medication management for geriatric patients.
• Comprehensive suite of pharmacy and consulting services.
• Network of pharmacies and distribution centers across the United States.

What Does PMC Do?

Pharmerica Corporation was founded with the mission of providing comprehensive pharmacy services to institutional healthcare settings. Over the years, the company has evolved into a leading provider of pharmacy and consulting services, primarily serving long-term care facilities, assisted living communities, and other healthcare institutions. Pharmerica's core offerings include medication dispensing, clinical consulting, and specialized pharmacy solutions designed to improve patient outcomes and reduce healthcare costs. The company's geographic reach extends across the United States, with a network of pharmacies and distribution centers strategically located to serve its diverse customer base. Pharmerica differentiates itself through its focus on medication management programs tailored to the unique needs of long-term care residents, including medication therapy management, adherence programs, and electronic health record integration. The company also provides consulting services to help facilities optimize their pharmacy operations, improve medication safety, and ensure regulatory compliance. Pharmerica's commitment to quality and innovation has established it as a trusted partner for healthcare providers seeking to enhance the delivery of pharmaceutical care.

What Products and Services Does PMC Offer?

• Provides medication dispensing services to long-term care facilities.
• Offers clinical consulting services to optimize medication management.
• Implements medication therapy management programs.
• Provides electronic health record integration solutions.
• Offers medication adherence programs.
• Provides specialized pharmacy solutions for specific patient populations.
• Assists facilities with regulatory compliance.

How Does PMC Make Money?

• Generates revenue from dispensing medications to long-term care facilities.
• Earns fees for providing clinical consulting services.
• Contracts with healthcare providers to manage pharmacy operations.
• Offers specialized pharmacy programs for specific patient populations.

What Industry Does PMC Operate In?

Pharmerica Corporation operates within the healthcare services industry, specifically focusing on institutional pharmacy services for long-term care facilities. The industry is characterized by increasing demand due to the aging population and the growing need for specialized medication management. The competitive landscape includes other national and regional pharmacy providers, as well as in-house pharmacy solutions offered by some healthcare systems. Market trends include the adoption of technology to improve medication safety and efficiency, as well as increasing regulatory scrutiny of pharmacy practices.

Who Are PMC's Key Customers?

• Long-term care facilities
• Assisted living communities
• Skilled nursing facilities
• Other healthcare institutions

Company Profile

Pharmerica Corporation operates in the Medical - Equipment & Services industry within the Healthcare sector. PMC has traded publicly since 2007.

ROE 4%Key Financial Metrics

Return on equity for Pharmerica Corporation stands at 4.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.7%, showing how much profit it generates from its asset base. PMC trades at a trailing price-to-earnings ratio of 41.57, above the Healthcare sector average of ~23x. A current ratio of 3.03 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.4%, the inverse of the P/E and a quick read on earnings relative to price.

Net sellingInsider Activity

The most recent 11 insider filings for Pharmerica Corporation break down as 9 sales and 2 purchases. On net that is roughly 772K shares disposed (about $19.2M), a signal worth weighing alongside the fundamentals.

PMC Financials

PMC Latest News

No recent news available for PMC.

PMC Analyst Consensus

PMC MoonshotScore

Common Questions About PMC (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources